Dr. Lal PathLabs Limited (NSE:LALPATHLAB)

Market Cap	237.42B +3.7%
Revenue (ttm)	26.63B +10.8%
Net Income	5.28B +26.8%
EPS	31.63 +26.5%
Shares Out	167.11M
PE Ratio	44.92
Forward PE	42.67
Dividend	14.00 (1.00%)
Ex-Dividend Date	Feb 5, 2026

Volume	141,058
Average Volume	265,960
Open	1,405.70
Previous Close	1,398.70
Day's Range	1,396.40 - 1,449.00
52-Week Range	1,146.78 - 1,770.00
Beta	0.01
RSI	48.89
Earnings Date	Jan 30, 2026

About Dr. Lal PathLabs

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1949
• Employees: 4,980
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: LALPATHLAB

Financial Performance

In fiscal year 2025, Dr. Lal PathLabs's revenue was 24.61 billion, an increase of 10.54% compared to the previous year's 22.27 billion. Earnings were 4.87 billion, an increase of 36.17%.